Revelation Biosciences Inc (REVB) — Capital Reinvestment Ratio
Revelation Biosciences Inc (REVB) has a Capital Reinvestment Ratio of 0.04x as of December 2018, meaning it reinvests 0% of its operating cash flow ($8.43 Million) in capital expenditures ($349.00K). See how leveraged is Revelation Biosciences Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Revelation Biosciences Inc Capital Reinvestment Ratio (2015–2019)
This chart tracks Revelation Biosciences Inc's Capital Reinvestment Ratio across 5 annual periods. Check REVB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Revelation Biosciences Inc (2015–2019)
Year-by-year Capital Reinvestment Ratio for Revelation Biosciences Inc from 2015 to 2019. For live market cap and broader valuation context, see how much is Revelation Biosciences Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.01x | $41.09 Million | $526.00K | ▼ -51.6% |
| 2018 | 0.03x | $32.58 Million | $861.00K | ▼ -20.3% |
| 2017 | 0.03x | $24.25 Million | $804.00K | ▼ -33.9% |
| 2016 | 0.05x | $11.60 Million | $582.00K | ▲ +0.0% |
| 2015 | 0.05x | $11.60 Million | $582.00K | — |